Literature DB >> 11481249

Integrin-linked kinase as a candidate downstream effector in proteinuria.

M Kretzler1, V P Teixeira, P G Unschuld, C D Cohen, R Wanke, I Edenhofer, P Mundel, D Schlöndorff, H Holthöfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11481249     DOI： 10.1096/fj.00-0832fje

Source DB:  PubMed          Journal:  FASEB J        ISSN： 0892-6638            Impact factor:   5.191


× No keyword cloud information.
  32 in total

1.  Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis.

Authors:  D Kerjaschki
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  Dynamic (re)organization of the podocyte actin cytoskeleton in the nephrotic syndrome.

Authors:  Jun Oh; Jochen Reiser; Peter Mundel
Journal:  Pediatr Nephrol       Date:  2003-12-13       Impact factor: 3.714

3.  Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria.

Authors:  Young Sun Kang; Yingjian Li; Chunsun Dai; Lawrence P Kiss; Chuanyue Wu; Youhua Liu
Journal:  Kidney Int       Date:  2010-05-26       Impact factor: 10.612

Review 4.  Cell-matrix adhesion of podocytes in physiology and disease.

Authors:  Norman Sachs; Arnoud Sonnenberg
Journal:  Nat Rev Nephrol       Date:  2013-01-22       Impact factor: 28.314

Review 5.  Cell biology and pathology of podocytes.

Authors:  Anna Greka; Peter Mundel
Journal:  Annu Rev Physiol       Date:  2011-11-04       Impact factor: 19.318

Review 6.  Podocyte-actin dynamics in health and disease.

Authors:  Luca Perico; Sara Conti; Ariela Benigni; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 7.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

Review 8.  The parvins.

Authors:  J L Sepulveda; C Wu
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

9.  Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Authors:  Monica Locatelli; Simona Buelli; Anna Pezzotta; Daniela Corna; Luca Perico; Susanna Tomasoni; Daniela Rottoli; Paola Rizzo; Debora Conti; Joshua M Thurman; Giuseppe Remuzzi; Carlamaria Zoja; Marina Morigi
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

Review 10.  Proteinuria: an enzymatic disease of the podocyte?

Authors:  Peter Mundel; Jochen Reiser
Journal:  Kidney Int       Date:  2009-11-18       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.